FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/065066 [Registered on: 02/04/2024] Trial Registered Prospectively
Last Modified On: 25/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   Studying for presence of Glaucoma in Different Stages of Diabetic Eye Disease: A research study. 
Scientific Title of Study   Evaluation for Glaucoma in Mild, Moderate and Severe Non-Proliferative Diabetic Retinopathy - A Prospective Observational Study  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ishita Kak 
Designation  Primary DNB Resident 
Affiliation  Centre for sight eye institute  
Address  Centre For Sight Eye Institute, Plot No 9 Sector 9 Dwarka, Delhi
Centre For Sight Eye Institute, Plot No 9 Sector 9 Dwarka, Delhi
South West
DELHI
110077
India 
Phone  9996681257  
Fax    
Email  kak.ishita18@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Maj Gen Dr Sagarika Patyal 
Designation  Head of Department of Ophthalmology  
Affiliation  Centre for sight eye institute  
Address  Centre for sight eye institute plot no 9 sector 9 dwarka delhi

South West
DELHI
110077
India 
Phone  9643437024  
Fax    
Email  sagarikapatyal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Maj Gen Dr Sagarika Patyal 
Designation  Head of Department of Ophthalmology 
Affiliation  Centre for sight eye institute 
Address  Centre for sight eye institute plot no 9 sector 9 dwarka delhi

South West
DELHI
110077
India 
Phone  9643437024  
Fax    
Email  sagarikapatyal@gmail.com  
 
Source of Monetary or Material Support  
Centre For Sight Eye Institute Dwarka 
 
Primary Sponsor
Modification(s)  
Name  Ishita kak 
Address  Centre for sight eye hospital Dwarka new delhi 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
Centre for sight eye institute Dwarka   Centre for sight eye institute plot no 9 sector 9 dwarka delhi 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Maj Gen Dr Sagarika Patyal  Centre For Sight Eye Institute  Room No Diagnostic 3, 2nd floor, Department of Ophthalmology
South West
DELHI 
9643437024

sagarikapatyal@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Centre For Sight Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H00-H59||Diseases of the eye and adnexa,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Mild moderate severe NPDR with or without macular edema with vision greater than 6 by 24 , post intravitreal injections, post focal laser , none treatment  
 
ExclusionCriteria 
Details  Advanced glaucoma Co-existing macular ischemia Co-existing juxtafoveal telangiectasia Proliferative Diabetic Retinopathy Retinal Dystrophy and Degeneration Optic atrophy Post Vitero-Retina surgeries Associated CRAO BRAO BRVO CRVO Past History of uveitis diabetic papillopathy papilloedema History of Trauma Cataract PCO Myopia Amblyopia 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To find the Incidence of Glaucoma in mild, moderate and severe Non Proliferative Diabetic Retinopathy  At the end of 24 months 
 
Secondary Outcome  
Outcome  TimePoints 
To determine sensitivity & specificity of various standard diagnostic tests viz a viz optic nerve head findings Pachymetry Automated Visual Field Tesing & OCT Retinal Nerve Fiber Layer Ganglion Cell Complex for Glaucoma diagnosis in NPDR patients  At the end of 26 months 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   According to a study Diabetic Retinopathy might be associated with Glaucoma however certain studies do not agree with this association leading to ongoing discussions and research on this matter hence this study will contribute to understanding the coexistence of Non Proliferative Diabetic Retinopathy and Glaucoma by providing valuable insights into the incidence and diagnostic accuracy thus aiding in early diagnosis and timely treatment of patients 
Close